Journal
AMERICAN JOURNAL OF PSYCHIATRY
Volume 162, Issue 8, Pages 1483-1493Publisher
AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.162.8.1483
Keywords
-
Categories
Funding
- NCRR NIH HHS [M01 RR-00125, M01 RR-01070-26] Funding Source: Medline
- NIAMS NIH HHS [1 P50 AR-049551] Funding Source: Medline
- NIDA NIH HHS [1 P50 DA-016556, K02-DA-017232, K24 DA-00435-04] Funding Source: Medline
Ask authors/readers for more resources
The high rate of co-occurrence of substance use disorders and other psychiatric disorders is well established. The population of people with co-occurring disorders is heterogeneous, and the prevalence of comorbidity differs by diagnostic group. One of the overarching issues in the area of comorbidity is the nature of the connection between psychiatric disorders and substance use disorders. The rapid development of technical advances in the neurosciences has led to a better understanding of the molecular biology, neurotransmitter systems, and neural circuitry involved in mental illness and substance use disorders. The authors discuss the neurobiological interface between substance use disorders and other psychiatric disorders with an emphasis on emerging data concerning four psychiatric disorders that commonly co-occur with substance use disorders: depression/mood disorders, posttraumatic stress disorder, attention deficit hyperactivity disorder, and schizophrenia. Better understanding of the connection between substance use disorders and psychiatric disorders could have a profound effect on prevention and treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available